Rene Lemieux, Ph.D., serves as senior vice president and head of drug discovery at Faze Medicines. Rene is an accomplished executive with more than two decades of experience and proven leadership successfully delivering drug discovery pipelines and overseeing agile drug discovery infrastructure from validated biological target to IND in a startup environment. Rene is an inventor of Tibsovo® (ivosidenib). He also has more than 50 patent applications, peer reviewed articles and presentations and is a co-inventor of 23 issued US patents. Prior to Faze, Rene served as discovery consultant at Third Rock Ventures, vice president and head of small molecule drug discovery at KSQ Therapeutics, director of medicinal chemistry at Agios Pharmaceuticals, and held several senior research positions over 13 years at Boehringer Ingelheim Pharmaceuticals. He received his Ph.D. in organic chemistry from the University of British Columbia.
Rene enjoys running, walking with his dog and landscape photography.